{"schema_version":"secwatch.filing_event.v1","accession":"0001447362-22-000074","form_type":"8-K","ticker":"CSTL","cik":"0001447362","company_name":"CASTLE BIOSCIENCES INC","filed_at":"2022-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.760946+00:00","generated_at":"2026-06-26T02:00:33.530699+00:00","sec_items":["3.02"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Castle Biosciences completes AltheaDx acquisition; issues 763,887 shares","bullets":["$65M initial consideration: $32.5M cash and $32.5M in stock (763,887 shares).","Up to $75M in milestone payments through Dec 31, 2024; 50% cash, 50% stock.","Max shares issuable capped at 1,271,718; up to 507,831 more for milestones.","Shares unregistered under Section 4(a)(2)/Reg D; resale registration due in 40 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001447362-22-000074","json":"https://secwatch.observer/filing/0001447362-22-000074.json","markdown":"https://secwatch.observer/filing/0001447362-22-000074.md","text":"https://secwatch.observer/filing/0001447362-22-000074.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1447362/000144736222000074/0001447362-22-000074-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1447362/000144736222000074/cstl-20220426.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T02:00:33.530699+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}